🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Martin Fan

Stock Analyst at Wedbush

(4.49)
# 1,140
Out of 5,189 analysts
88
Total ratings
36.4%
Success rate
23.2%
Average return

Stocks Rated by Martin Fan

Immunic
Nov 18, 2026
Maintained: Buy
Price Target: $45
Current: $6.99
Upside: +543.78%
Aclaris Therapeutics
Nov 17, 2026
Downgraded: Hold
Price Target: $8 → $3
Current: $3.44
Upside: -12.79%
TRex Bio
Nov 16, 2026
Reiterated: Buy
Price Target: $30
Current: $10.32
Upside: +190.84%
Eupraxia Pharmaceuticals Inc.
Nov 16, 2026
Reiterated: Buy
Price Target: $24.32
Current: $8.34
Upside: +191.63%
Nektar Therapeutics
Nov 13, 2026
Reiterated: Hold
Price Target: $50 → $40
Current: $30.20
Upside: +32.45%
Zura Bio
Nov 9, 2026
Reiterated: Buy
Price Target: $22 → $10
Current: $0.9305
Upside: +974.69%
Fate Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $7
Current: $0.919
Upside: +661.70%
Cartesian Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $38
Current: $6.14
Upside: +518.89%
Sana Biotechnology
Nov 6, 2026
Reiterated: Buy
Price Target: $7
Current: $1.59
Upside: +340.25%
Zenas BioPharma
Nov 6, 2026
Reiterated: Buy
Price Target: $45
Current: $23.85
Upside: +88.68%
Reiterated: Buy
Price Target: $70
Current: $41.64
Upside: +68.11%
Downgraded: Hold
Price Target: $40 → $4
Current: $3.78
Upside: +5.82%
Reiterated: Buy
Price Target: $165
Current: $95.81
Upside: +72.22%
Reiterated: Hold
Price Target: $18 → $27
Current: $19.19
Upside: +40.70%
Reiterated: Sell
Price Target: $2
Current: $3.92
Upside: -48.98%
Reiterated: Buy
Price Target: $46
Current: $46.13
Upside: -0.28%
Reiterated: Buy
Price Target: $40 → $45
Current: $46.63
Upside: n/a